How to Treat

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), and accounts for about a quarter of cases in the United States, with more than 27,000 new cases identified each year.

Most patients with follicular lymphoma (FL) will experience a pattern of relapse and remission and require numerous lines of treatments throughout their lifetime. Learn about different regimens and risk-stratification for high-risk FL.